½ÃÀ庸°í¼­
»óǰÄÚµå
1610245

¼¼°èÀÇ ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå : Á¦Ç° À¯Çü, ¾àÁ¦ À¯Çü, ¼ÒÀç, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Pharmaceutical Glass Packaging Market by Product (Ampoules, Bottles & Jars, Cartridges & Syringes), Drug Type (Biologic, Branded, Generic), Material, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 190¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 209¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 10.59%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 385¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå¿¡´Â ÀǾàǰ ¹× ¹ÙÀÌ¿À ÀǾàǰ Æ÷Àå¿¡ »ç¿ëµÇ´Â À¯¸® ¿ë±âÀÇ »ý»ê°ú °ø±ÞÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Æ÷ÀåÀÇ Çʿ伺Àº ¿À¿°À» ¹æÁöÇϰí ÀǾàǰÀÇ È¿°ú¸¦ À¯ÁöÇÏ´Â À¯¸®ÀÇ ºÒȰ¼º Ư¼ºÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ±×¸®°í º´¿ø, Á¦¾à ȸ»ç, ¿¬±¸¼Ò¿¡¼­ ÃÖÁ¾ ¿ëµµ°¡ ¸¹½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ÀǾàǰ ¼ö¿ä Áõ°¡, »ý¹° Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ È®´ë, ÀǾàǰ ¾ÈÀü¼º ¹× Æ÷Àå ±âÁØ¿¡ °üÇÑ ±ÔÁ¦ °­È­ µîÀÌ ÀÖ½À´Ï´Ù. Áö¼Ó °¡´ÉÇÑ Æ÷ÀåÀç ¼ö¼ö·á¿¡ ´ëÇÑ µ¿Çâ°ú ´õºÒ¾î ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í °­È­ÇÒ °ÍÀÔ´Ï´Ù. ½ÅÈï ½ÃÀåÀº ÇコÄɾîÀÇ ¿ä±¸°¡ ³ô¾ÆÁö°í Àֱ⠶§¹®¿¡ È®´ëÀÇ ¿©Áö°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³¼±µÈ Ư¼ºÀ» °¡Áø ÇÃ¶ó½ºÆ½°ú °°Àº ´ëüǰÀÇ À§Çùµµ Á¦¾àÀ» ¹Þ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ º¯È¯ÀÇ È°¿ë¿¡ ÃÊÁ¡À» ¸ÂÃß¾î¾ß Çϸç, ÃßÀû ±â´ÉÀ» °®Ãá ½º¸¶Æ® ÆÐŰ¡ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀº °æÀï ¿ìÀ§¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ´ë±â¾÷Àº ºÎ°¡°¡Ä¡°¡ ³ôÀº Á¦Ç°À» âÃâÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 190¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 209¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 385¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 10.59%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ÀÌ´Â Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀǾàǰ ºÎ¹®¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • ¹é½Å°ú ÀǾàǰ ¼Òºñ Áõ°¡
    • ÀǾàǰÀÇ Àå±â º¸Á¸ÀÇ Çʿ伺
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • À¯¸® Æ÷ÀåÀÇ Á¦Á¶¿¡ »ç¿ëµÇ´Â ¿øÀç·áÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • Çõ½ÅÀûÀÎ ÀǾàǰ À¯¸® Æ÷Àå °³¹ß
    • Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ Æ÷Àå ¼Ö·ç¼ÇÀÇ ÃâÇö
  • ½ÃÀåÀÇ °úÁ¦
    • ÀǾàǰ À¯¸® Æ÷Àå°ú °ü·ÃµÈ ȯ°æ ¹®Á¦

Porter's Five Force : ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϰí, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÀǾàǰ ºÐ¾ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
      • ¹é½Å°ú ÀǾàǰ ¼Òºñ·® Áõ°¡
      • ÀǾàǰÀÇ º¸Á¸ ±â°£ ¿¬ÀåÀÇ Çʿ伺
    • ¾ïÁ¦¿äÀÎ
      • À¯¸® ¿ë±âÀÇ Á¦Á¶¿¡ »ç¿ëµÇ´Â ¿øÀç·áÀÇ °íºñ¿ë
    • ±âȸ
      • Çõ½ÅÀûÀÎ ÀǾàǰ À¯¸® Æ÷Àå °³¹ß
      • Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ Æ÷Àå ¼Ö·ç¼ÇÀÇ ÃâÇö
    • °úÁ¦
      • ÀǾàǰ À¯¸® Æ÷Àå°ú °ü·ÃµÈ ȯ°æ ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå : Á¦Ç°º°

  • ¾ÚÇ®
  • º¸Æ² ¹× º´
  • īƮ¸®Áö ¹× ÁÖ»ç±â
  • ¹ÙÀ̾Ë

Á¦7Àå ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå : ¾à À¯Çüº°

  • »ý¹°Á¦Á¦
  • ºê·£µå
  • Á¦³×¸¯

Á¦8Àå ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå : ¼ÒÀ纰

  • À¯Çü I
  • À¯Çü II
  • À¯Çü III

Á¦9Àå ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå : ¿ëµµº°

  • ÁÖ»ç °¡´É
  • ºñ°­
  • °æ±¸

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀǾàǰ À¯¸® Æ÷Àå ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Acme Vial and Glass Company, LLC
  • Ajanta Bottle Pvt. Ltd.
  • Arab Pharmaceutical Glass Company
  • Ardagh Group SA
  • Bormioli Pharma Srl
  • Haldyn Glass Gujrat Ltd.
  • Hindusthan National Glass & Industries Limited
  • Jiangsu Rongtai Glass Products Co., Ltd.
  • Nipro Corporation
  • Origin Pharma Packaging
  • PGP Glass Private Limited
  • Schott AG
  • Shandong Medicinal Glass Co., Ltd.
  • Stevanato Group
  • Stolzle-Oberglas GmbH
  • West Pharmaceutical Services, Inc.
JHS 24.12.20

The Pharmaceutical Glass Packaging Market was valued at USD 19.04 billion in 2023, expected to reach USD 20.99 billion in 2024, and is projected to grow at a CAGR of 10.59%, to USD 38.54 billion by 2030.

The pharmaceutical glass packaging market encompasses the production and supply of glass containers used for packaging drugs and biopharmaceutical products. Primarily, this includes vials, ampoules, bottles, and cartridges, vital for maintaining drug stability and ensuring shelf-life integrity. The necessity for such packaging arises from glass's inert nature, which prevents contamination and preserves the efficacy of pharmaceutical products. Its application spans injectable drugs, oral liquids, nasal and respiratory applications, with significant end-use in hospitals, pharmaceutical companies, and research labs. Key growth factors include increasing drug demand, expansion in biologics and biosimilars, and stricter regulations on drug safety and packaging standards. The rise in chronic diseases and an aging population further bolster market growth, alongside a trend toward sustainable packaging materials. Opportunities in the sector lie in the development of advanced glass types, including chemically strengthened or lightweight options, providing superior protection while reducing shipping costs. Moreover, emerging markets present avenues for expansion due to their increasing healthcare needs. However, challenges include the high cost of producing medical-grade glass and the vulnerability of glass to damage, leading to potential drug wastage. The threat of substitute materials, like plastic with improved properties, also poses a limitation. Innovation should focus on cost-effective manufacturing technologies, enhancing glass durability, and leveraging digital transformation to improve supply chain efficiency. Additionally, adopting smart packaging solutions with track-and-trace capabilities could provide competitive advantages. The market is characterized by competitive dynamics with major players investing heavily in R&D to create value-added products. Collaborations between manufacturers and pharmaceutical companies will be crucial to align packaging innovations with the evolving requirements of the pharmaceutical landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 19.04 billion
Estimated Year [2024] USD 20.99 billion
Forecast Year [2030] USD 38.54 billion
CAGR (%) 10.59%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Glass Packaging Market

The Pharmaceutical Glass Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing investments in the pharmaceutical sector
    • Rising consumption of vaccines and drugs
    • Need for longer shelf life of pharmaceutical products
  • Market Restraints
    • High cost of raw materials used in production of glass packaging
  • Market Opportunities
    • Development of innovative pharmaceutical glass packaging
    • Emergence of sustainable and eco-friendly packaging solutions
  • Market Challenges
    • Environmental concerns associated with pharmaceutical glass packaging

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Glass Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Glass Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Glass Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Glass Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Glass Packaging Market

A detailed market share analysis in the Pharmaceutical Glass Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Glass Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Glass Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Glass Packaging Market

A strategic analysis of the Pharmaceutical Glass Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Glass Packaging Market, highlighting leading vendors and their innovative profiles. These include Acme Vial and Glass Company, LLC, Ajanta Bottle Pvt. Ltd., Arab Pharmaceutical Glass Company, Ardagh Group S.A., Bormioli Pharma S.r.l., Haldyn Glass Gujrat Ltd., Hindusthan National Glass & Industries Limited, Jiangsu Rongtai Glass Products Co., Ltd., Nipro Corporation, Origin Pharma Packaging, PGP Glass Private Limited, Schott AG, Shandong Medicinal Glass Co., Ltd., Stevanato Group, Stolzle-Oberglas GmbH, and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Glass Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Ampoules, Bottles & Jars, Cartridges & Syringes, and Vials.
  • Based on Drug Type, market is studied across Biologic, Branded, and Generic.
  • Based on Material, market is studied across Type I, Type II, and Type III.
  • Based on Application, market is studied across Injectable, Nasal, and Oral.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing investments in the pharmaceutical sector
      • 5.1.1.2. Rising consumption of vaccines and drugs
      • 5.1.1.3. Need for longer shelf life of pharmaceutical products
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of raw materials used in production of glass packaging
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of innovative pharmaceutical glass packaging
      • 5.1.3.2. Emergence of sustainable and eco-friendly packaging solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental concerns associated with pharmaceutical glass packaging
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Glass Packaging Market, by Product

  • 6.1. Introduction
  • 6.2. Ampoules
  • 6.3. Bottles & Jars
  • 6.4. Cartridges & Syringes
  • 6.5. Vials

7. Pharmaceutical Glass Packaging Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Biologic
  • 7.3. Branded
  • 7.4. Generic

8. Pharmaceutical Glass Packaging Market, by Material

  • 8.1. Introduction
  • 8.2. Type I
  • 8.3. Type II
  • 8.4. Type III

9. Pharmaceutical Glass Packaging Market, by Application

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Nasal
  • 9.4. Oral

10. Americas Pharmaceutical Glass Packaging Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmaceutical Glass Packaging Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Glass Packaging Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acme Vial and Glass Company, LLC
  • 2. Ajanta Bottle Pvt. Ltd.
  • 3. Arab Pharmaceutical Glass Company
  • 4. Ardagh Group S.A.
  • 5. Bormioli Pharma S.r.l.
  • 6. Haldyn Glass Gujrat Ltd.
  • 7. Hindusthan National Glass & Industries Limited
  • 8. Jiangsu Rongtai Glass Products Co., Ltd.
  • 9. Nipro Corporation
  • 10. Origin Pharma Packaging
  • 11. PGP Glass Private Limited
  • 12. Schott AG
  • 13. Shandong Medicinal Glass Co., Ltd.
  • 14. Stevanato Group
  • 15. Stolzle-Oberglas GmbH
  • 16. West Pharmaceutical Services, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦